These novel findings support the observation that NKG2D contributes to the tumor-promoting environment in CRC and highlight the need to better understand the mechanisms underlying NKG2D-mediated cancer immunosurveillance in different subsets of CRC to develop targeted therapies. The gene discussed is KLRK1; the disease is neoplasm.